Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 12, Issue 7 (2023)

Studies of combining ability in maize (Zea mays L.,) hybrids using Line x Tester analysis

Author(s):
Dinesh Kumar Thakur, SK Sinha, Vivek Kumar Sandilya, Sandip P Patil and Devarchan Nirala
Abstract:
The present study was conducted during Kharif 2022 using total 56 maize entries (including 40 maize hybrids, 13 parents and 3 standard checks) to assess the combining ability for grain yield and its contributing traits. IAMI 123, IAMI 112 and HKI 163 were found good general combiner for most of the traits among all the parental line. IAMI 123 was to be a good general combiner for grain yield (q/ha), final plant stand (thousand/ha) and No of ears (thousand/ha). For 100 grain wt (g), IAMI 112 and the traits viz., final plant stand (thousand/ha), No. of ears (thousand/ha), No. of kernel rows/ ear, tester HKI 163 was to be a good general combiner. For earliness traits viz., days to 50% tasseling, days to 50% silking, days to 80% brown husk maturity IAMI 112, IAMI123 and HKI 163 were found good general combiner. Among the testers LM 13 would be a good general combiner for grain yield (q/ha), 100 grain wt (g) and ear length (cm), while BML 6 is good for earliness (days to 80% brown husk maturity) and No. of kernel rows/ear. For grain yield (q/ha) a close examine of the results with respects to sca effects indicated that only seven crosses viz., IAMI-101 X LM-13, IAMI-112 X HKI-163, IAMI-112 X CML-451, IAMI-118 X LM-13, IAMI-121 X CML-451, IAMI-123 X LM-14 and IAMI-123 X BML-6 were found significant sca among forty crosses. Therefore, these hybrids are considered as best specific combiner for grain yield (q/ha) and would be used in a hybridization programme.
Pages: 1774-1778  |  265 Views  198 Downloads


The Pharma Innovation Journal
How to cite this article:
Dinesh Kumar Thakur, SK Sinha, Vivek Kumar Sandilya, Sandip P Patil, Devarchan Nirala. Studies of combining ability in maize (Zea mays L.,) hybrids using Line x Tester analysis. Pharma Innovation 2023;12(7):1774-1778.

Call for book chapter